AKT1 and hepatocellular carcinoma: The most recent has uncovered that STV effectively inhibited hepatocellular carcinoma (HepG2 and Huh7 cells) both in vitro and in vivo by modulation of NF‐κB and PI3K/Akt signaling (Guo et al. 2024).